AHEALTH | APEX HEALTHCARE BERHAD

2.84 (-0.35%)
0

T-O (am): 0.000 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

AHEALTH | APEX HEALTHCARE BERHAD


iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
15 May 24 Q1 Mar 24 1 31 Dec 24 248.18 26.30 21.21 8.6% 0.00 2.97 3.4% 1.0% 5.7% 12.7%
21 Feb 24 Q4 Dec 23 4 31 Dec 23 240.00 28.64 20.06 8.4% 22.50 2.81 2.0% 8.8% 17.0% 42.4%
29 Nov 23 Q3 Sep 23 3 31 Dec 23 235.34 30.48 24.16 10.3% 0.00 3.38 9.4% 1.4% 92.7% 10.1%
23 Aug 23 Q2 Jun 23 2 31 Dec 23 215.03 334.52 329.48 153.2% 2.50 46.13 12.5% 2.8% 1256.9% 1302.7%
24 May 23 Q1 Mar 23 1 31 Dec 23 245.80 29.67 24.28 9.9% 0.00 5.12 11.5% 13.8% 30.3% 54.0%
22 Feb 23 Q4 Dec 22 4 31 Dec 22 220.49 40.29 34.84 15.8% 5.50 7.34 5.0% 11.6% 29.6% 68.2%
16 Nov 22 Q3 Sep 22 3 31 Dec 22 232.08 32.40 26.88 11.6% 0.00 5.67 10.9% 10.0% 14.4% 91.9%
16 Aug 22 Q2 Jun 22 2 31 Dec 22 209.25 27.85 23.49 11.2% 3.00 4.95 3.1% 14.6% 49.0% 83.2%
18 May 22 Q1 Mar 22 1 31 Dec 22 215.92 19.82 15.77 7.3% 0.00 3.33 9.2% 20.3% 23.8% 32.8%
23 Feb 22 Q4 Dec 21 4 31 Dec 21 197.66 25.30 20.70 10.5% 9.00 4.37 6.3% 22.3% 47.8% 43.8%
17 Nov 21 Q3 Sep 21 3 31 Dec 21 211.06 18.55 14.01 6.6% 0.00 2.96 15.6% 24.8% 9.2% 1.5%
19 Aug 21 Q2 Jun 21 2 31 Dec 21 182.56 16.12 12.82 7.0% 2.50 2.71 1.7% 4.5% 8.0% 1.6%
20 May 21 Q1 Mar 21 1 31 Dec 21 179.49 15.44 11.88 6.6% 0.00 2.51 11.1% 7.2% 17.5% 17.3%
25 Feb 21 Q4 Dec 20 4 31 Dec 20 161.58 18.40 14.39 8.9% 2.80 3.04 4.5% 5.3% 1.2% 2.8%
19 Nov 20 Q3 Sep 20 3 31 Dec 20 169.12 17.49 14.22 8.4% 0.00 3.01 3.2% 6.4% 9.1% 0.7%
26 Aug 20 Q2 Jun 20 2 31 Dec 20 174.73 16.34 13.03 7.5% 1.70 2.76 9.6% 9.7% 9.3% 1.4%
21 May 20 Q1 Mar 20 1 31 Dec 20 193.31 17.94 14.37 7.4% 0.00 3.05 13.3% 8.5% 2.6% 26.1%
19 Feb 20 Q4 Dec 19 4 31 Dec 19 170.63 18.48 14.00 8.2% 2.00 2.97 5.5% 4.6% 0.8% 16.7%
21 Nov 19 Q3 Sep 19 3 31 Dec 19 180.65 17.12 14.12 7.8% 0.00 3.00 13.4% 15.8% 6.8% 3.1%
21 Aug 19 Q2 Jun 19 2 31 Dec 19 159.27 16.18 13.22 8.3% 1.70 2.81 10.6% 5.4% 16.0% 0.3%
23 May 19 Q1 Mar 19 1 31 Dec 19 178.23 14.54 11.40 6.4% 0.00 9.71 9.3% 16.8% 32.2% 10.9%
28 Feb 19 Q4 Dec 18 4 31 Dec 18 163.06 16.74 16.80 10.3% 7.00 14.33 4.6% 3.4% 22.7% 49.1%
16 Aug 18 Q2 Jun 18 2 31 Dec 18 155.95 17.37 13.70 8.8% 6.50 11.69 7.4% 0.4% 3.9% 33.0%
24 May 18 Q1 Mar 18 1 31 Dec 18 168.40 16.53 13.18 7.8% 0.00 11.25 10.4% 8.9% 3.0% 30.6%
22 Feb 18 Q4 Dec 17 4 31 Dec 17 152.59 16.38 12.80 8.4% 6.50 10.93 3.3% 5.8% 13.6% 89.5%
14 Nov 17 Q3 Sep 17 3 31 Dec 17 157.73 13.30 11.27 7.2% 0.00 9.62 1.6% 10.3% 9.4% 29.0%
16 Aug 17 Q2 Jun 17 2 31 Dec 17 155.30 13.45 10.30 6.6% 5.50 8.79 0.4% 5.9% 2.0% 6.7%
17 May 17 Q1 Mar 17 1 31 Dec 17 154.65 12.91 10.09 6.5% 0.00 8.61 7.3% 4.9% 49.4% 2.8%
23 Feb 17 Q4 Dec 16 4 31 Dec 16 144.15 10.08 6.76 4.7% 6.00 5.77 0.8% 7.4% 22.7% 51.1%
15 Nov 16 Q3 Sep 16 3 31 Dec 16 142.96 11.54 8.74 6.1% 0.00 7.46 2.5% 11.4% 9.5% 62.4%
17 Aug 16 Q2 Jun 16 2 31 Dec 16 146.69 12.31 9.65 6.6% 5.50 8.24 0.5% 18.0% 1.7% 46.1%
18 May 16 Q1 Mar 16 1 31 Dec 16 147.48 12.37 9.81 6.7% 0.00 8.38 9.8% 5.3% 28.9% 16.2%
25 Feb 16 Q4 Dec 15 4 31 Dec 15 134.25 16.91 13.81 10.3% 6.00 11.79 4.7% 8.9% 156.6% 44.6%
26 Nov 15 Q3 Sep 15 3 31 Dec 15 128.27 7.72 5.38 4.2% 0.00 4.59 3.2% 4.7% 18.5% 27.4%
19 Aug 15 Q2 Jun 15 2 31 Dec 15 124.28 9.08 6.60 5.3% 5.00 5.64 11.3% 1.5% 21.8% 12.6%
20 May 15 Q1 Mar 15 1 31 Dec 15 140.06 11.88 8.45 6.0% 0.00 7.21 13.6% 7.0% 11.5% 10.8%
25 Feb 15 31/12/14 4 31/12/14 123.31 12.67 9.54 7.7% 6.00 8.13 0.7% 16.1% 28.8% 25.3%

Historical Dividends

Financial Ratios

EPS 54.88 sen
Trailing PE (Sector Median: 20.6) 5.2
PEG 5.2
Altman Z 3.5
Beaver 0.011
Current Ratio 3.9
Debt-Equity (DE) Ratio 0.21
FCF Yield -0.05 %
Revenue QoQ 3.41 %
Revenue YoY 0.97%
Profit QoQ 5.72 %
Profit YoY -12.66 %
Profit Margin (Sector Median: 6.8) 42.08 %
ROE (ROIC: 41.79) 41.79 %
Dividend Per Share (DPS) 25.0 sen
Dividend Yield (DY) 8.8 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 20.6)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 6.8)
ROE (ROIC: 8.48)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 3 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 1.32
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 21.21
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 243.8
Expected Revenue (M) 2021.55
Expected Growth (%) 17.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


MR KEE KIRK CHUEN added 29500.0 units announced on 22 Jan 2024 at ~RM2.54

DR KEE KIRK CHIN added 29500.0 units announced on 22 Jan 2024 at ~RM2.54

MR KEE KIRK CHUEN added 115000.0 units announced on 12 Jan 2024 at ~RM2.57

DR KEE KIRK CHIN added 115000.0 units announced on 12 Jan 2024 at ~RM2.57

DR KEE KIRK CHIN added 27900.0 units announced on 27 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 27900.0 units announced on 27 Oct 2023 at ~RM2.4

DR KEE KIRK CHIN added 108000.0 units announced on 25 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 108000.0 units announced on 25 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 16200.0 units announced on 09 Oct 2023 at ~RM2.43

DR KEE KIRK CHIN added 16200.0 units announced on 09 Oct 2023 at ~RM2.43

MR KEE KIRK CHUEN added 35000.0 units announced on 05 Oct 2023 at ~RM2.44

DR KEE KIRK CHIN added 35000.0 units announced on 05 Oct 2023 at ~RM2.44

DR KEE KIRK CHIN added 195000.0 units announced on 26 Sep 2023 at ~RM2.46

MR KEE KIRK CHUEN added 195000.0 units announced on 26 Sep 2023 at ~RM2.46

MR KEE KIRK CHUEN added 46000.0 units announced on 22 Sep 2023 at ~RM2.49

DR KEE KIRK CHIN added 46000.0 units announced on 22 Sep 2023 at ~RM2.49

MR KEE KIRK CHUEN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

DR KEE KIRK CHIN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

MR KEE KIRK CHUEN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

DR KEE KIRK CHIN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

MR KEE KIRK CHUEN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

DR KEE KIRK CHIN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

MR LEONG KHAI CHEONG added 81600.0 units announced on 17 Oct 2022 at ~RM3.11

DR KEE KIRK CHIN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

DR KEE KIRK CHIN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

MR KEE KIRK CHUEN added 30000.0 units announced on 14 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 44000.0 units announced on 12 Jul 2022 at ~RM2.92

DR KEE KIRK CHIN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR KEE KIRK CHUEN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 76000.0 units announced on 08 Jul 2022 at ~RM2.9

MR ROBERT DOBSON MILLNER added 80000.0 units announced on 07 Jul 2022 at ~RM2.85

MR KEE KIRK CHUEN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

DR KEE KIRK CHIN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

MR KEE KIRK CHUEN added 30000.0 units announced on 13 Dec 2021 at ~RM2.57

DR KEE KIRK CHIN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 50000.0 units announced on 12 Mar 2021 at ~RM2.87

MR KEE KIRK CHUEN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

DR KEE KIRK CHIN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

Summary


Market Cap: 2043 M.

Number of Shares: 719 M.

Adjusted Float: 30.7%.

Stock highly correlated with

KKB (86%)

KPJ (86%)

UZMA (86%)

AMWAY (85%)

Apex Healthcare Berhad is an investment holding company. The company is engaged in the development, manufacturing, wholesaling, marketing, and distribution of pharmaceuticals, consumer healthcare products, and medical devices. For example range of products in the manufacturing segment include cough mixtures and antihistamines, anti-infectives, anti-diabetics, anti-hypertensives, neuromuscular agents, analgesics, dermatological and ophthalmological in the form of tablets, capsules, oral liquid, and suspension, creams, and sterile eyedrops. The company is also one of the distributors for internationally famous brands such as Nestle, 3M, and Rigel Pharma. It has direct operations in Malaysia, Singapore, Vietnam, and Myanmar. The company was founded in 1962 and is headquartered in Melaka, Malaysia.

Sectors: Pharmaceuticals, Healthcare, Vaccine

Code: 7090

Website: http://www.apexhealthcare.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

Top Shareholdings

Updated on 15-Mar-2024

Shareholder % Value (M)
Apex Pharmacy Holdings Sdn Bhd 39.72% 811.8
Washington H. Soul Pattinson And Company Limited 29.61% 605.17
Xepa Holdings Sdn Bhd 2.08% 42.55
Lim Teh Realty Sdn Berhad 1.36% 27.8
Md Ali Bin Md Dewal 1.01% 20.64
Public Islamic Opportunities Fund 1.01% 20.64
iCapital.Biz Berhad 0.89% 18.19
Liew Yoon Yee 0.84% 17.17
Tan Su-Ann 0.84% 17.17
DBS Bank 0.79% 16.15
Public Strategic Smallcap Fund 0.79% 16.15
Apex Holdings (Pte) Ltd 0.56% 11.49
Apex Holdings Ltd 0.56% 11.45
Chan Heng Koon 0.53% 10.83
Teoh Choon Neo @ Ivy Teoh Choon Neo 0.48% 9.81
Public Focus Select Fund 0.47% 9.61
Singam A/L Kumarasamy 0.46% 9.4
Yeo Lee Hee 0.39% 7.97
Kee Kirk Chin 0.38% 7.77
Wong Yee Hui 0.34% 6.95
Oh Siew Heong 0.33% 6.74
Tan Jin Thai 0.32% 6.54
PB Islamic SmallCap Fund 0.31% 6.34
Leong Wai Kuen 0.28% 5.72
Susy Ding 0.28% 5.72
Phua Kiap Wite 0.25% 5.11
Leong Khai Cheong 0.23% 4.7
Lim Khuan Eng 0.22% 4.5
Lai Yoon Kee 0.22% 4.5
Medical Fund 0.21% 4.29
Kee Kirk Chuen 0.2% 4.01
Dr Kee Kirk Chin 0.05% 1.02
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.